RXRX logo

RXRX Depreciation And Amortization

Annual D&A

$36.49 M
+$12.09 M+49.55%

December 31, 2024


Summary


Performance

RXRX Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$12.95 M
+$5.75 M+79.92%

December 31, 2024


Summary


Performance

RXRX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$36.49 M
+$5.40 M+17.36%

December 31, 2024


Summary


Performance

RXRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

RXRX Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+49.5%+79.9%+17.4%
3 y3 years+334.2%+79.9%+17.4%
5 y5 years+1366.2%+79.9%+17.4%

RXRX Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+334.2%at high+479.2%at high+334.2%
5 y5-yearat high+1366.2%at high+1411.2%at high+3794.8%
alltimeall timeat high+1366.2%at high+1411.2%at high+3794.8%

Recursion Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$36.49 M(+49.6%)
$12.95 M(+79.9%)
$36.49 M(+17.4%)
Sep 2024
-
$7.20 M(-19.7%)
$31.10 M(-1.2%)
Jun 2024
-
$8.97 M(+21.6%)
$31.48 M(+12.2%)
Mar 2024
-
$7.38 M(-2.3%)
$28.05 M(+15.0%)
Dec 2023
$24.40 M(+107.6%)
$7.55 M(-0.3%)
$24.40 M(+21.6%)
Sep 2023
-
$7.58 M(+36.7%)
$20.06 M(+29.7%)
Jun 2023
-
$5.54 M(+48.7%)
$15.47 M(+21.7%)
Mar 2023
-
$3.73 M(+16.0%)
$12.72 M(+8.2%)
Dec 2022
$11.76 M
$3.21 M(+7.5%)
$11.76 M(+9.1%)
Sep 2022
-
$2.99 M(+7.3%)
$10.78 M(+5.4%)
Jun 2022
-
$2.79 M(+0.7%)
$10.22 M(+4.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
$2.77 M(+23.7%)
$9.77 M(+16.2%)
Dec 2021
$8.40 M(+113.2%)
$2.24 M(-8.2%)
$8.40 M(+15.2%)
Sep 2021
-
$2.44 M(+4.5%)
$7.29 M(+27.6%)
Jun 2021
-
$2.33 M(+66.3%)
$5.71 M(+29.7%)
Mar 2021
-
$1.40 M(+24.6%)
$4.41 M(+11.8%)
Dec 2020
$3.94 M(+58.4%)
-
-
Dec 2020
-
$1.13 M(+31.3%)
$3.94 M(+39.9%)
Sep 2020
-
$857.00 K(-16.3%)
$2.82 M(+43.7%)
Jun 2020
-
$1.02 M(+9.3%)
$1.96 M(+109.3%)
Mar 2020
-
$937.00 K
$937.00 K
Dec 2019
$2.49 M
-
-

FAQ

  • What is Recursion Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals annual D&A year-on-year change?
  • What is Recursion Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals quarterly D&A year-on-year change?
  • What is Recursion Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals TTM D&A year-on-year change?

What is Recursion Pharmaceuticals annual depreciation & amortization?

The current annual D&A of RXRX is $36.49 M

What is the all time high annual D&A for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high annual depreciation & amortization is $36.49 M

What is Recursion Pharmaceuticals annual D&A year-on-year change?

Over the past year, RXRX annual depreciation & amortization has changed by +$12.09 M (+49.55%)

What is Recursion Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of RXRX is $12.95 M

What is the all time high quarterly D&A for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high quarterly depreciation & amortization is $12.95 M

What is Recursion Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, RXRX quarterly depreciation & amortization has changed by +$5.75 M (+79.92%)

What is Recursion Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of RXRX is $36.49 M

What is the all time high TTM D&A for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high TTM depreciation & amortization is $36.49 M

What is Recursion Pharmaceuticals TTM D&A year-on-year change?

Over the past year, RXRX TTM depreciation & amortization has changed by +$5.40 M (+17.36%)